Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer †
Titel:
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer †
Auteur:
Michiels, S. Pugliano, L. Marguet, S. Grun, D. Barinoff, J. Cameron, D. Cobleigh, M. Di Leo, A. Johnston, S. Gasparini, G. Kaufman, B. Marty, M. Nekljudova, V. Paluch-Shimon, S. Penault-Llorca, F. Slamon, D. Vogel, C. von Minckwitz, G. Buyse, M. Piccart, M.